Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
J Virol. 2018 Aug 29;92(18). doi: 10.1128/JVI.00276-18. Print 2018 Sep 15.
The host restriction factor tetherin inhibits virion release from infected cells and poses a significant barrier to successful zoonotic transmission of primate lentiviruses to humans. While most simian immunodeficiency viruses (SIV), including the direct precursors of human immunodeficiency virus type 1 (HIV-1) and HIV-2, use their Nef protein to counteract tetherin in their natural hosts, they fail to antagonize the human tetherin ortholog. Pandemic HIV-1 group M and epidemic group O strains overcame this hurdle by adapting their Vpu and Nef proteins, respectively, whereas HIV-2 group A uses its envelope (Env) glycoprotein to counteract human tetherin. Whether or how the remaining eight groups of HIV-2 antagonize this antiviral factor has remained unclear. Here, we show that Nef proteins from diverse groups of HIV-2 do not or only modestly antagonize human tetherin, while their ability to downmodulate CD3 and CD4 is highly conserved. Experiments in transfected cell lines and infected primary cells revealed that not only Env proteins of epidemic HIV-2 group A but also those of a circulating recombinant form (CRF01_AB) and rare groups F and I decrease surface expression of human tetherin and significantly enhance progeny virus release. Intriguingly, we found that many SIVsmm Envs also counteract human as well as smm tetherin. Thus, Env-mediated tetherin antagonism in different groups of HIV-2 presumably stems from a preadaptation of their SIVsmm precursors to humans. In summary, we identified a phenotypic trait of SIVsmm that may have facilitated its successful zoonotic transmission to humans and the emergence of HIV-2. HIV-2 groups A to I resulted from nine independent cross-species transmission events of SIVsmm to humans and differ considerably in their prevalence and geographic spread. Thus, detailed characterization of these viruses offers a valuable means to elucidate immune evasion mechanisms and human-specific adaptations determining viral spread. In a systematic comparison of rare and epidemic HIV-2 groups and their simian SIVsmm counterparts, we found that the ability of Nef to downmodulate the primary viral entry receptor CD4 and the T cell receptor CD3 is conserved, while effects on CD28, CD74, and major histocompatibility complex class I surface expression vary considerably. Furthermore, we show that not only the Env proteins of HIV-2 groups A, AB, F, and I but also those of some SIVsmm isolates antagonize human tetherin. This finding helps to explain why SIVsmm has been able to cross the species barrier to humans on at least nine independent occasions.
宿主限制因子 tetherin 抑制感染细胞中病毒的释放,并对灵长类慢病毒成功向人类的人畜共患病传播构成重大障碍。虽然大多数猿猴免疫缺陷病毒(SIV),包括人类免疫缺陷病毒 1 型(HIV-1)和 HIV-2 的直接前体,利用其 Nef 蛋白在其自然宿主中对抗 tetherin,但它们无法拮抗人类 tetherin 同源物。大流行的 HIV-1 组 M 和流行组 O 株通过分别适应其 Vpu 和 Nef 蛋白克服了这一障碍,而 HIV-2 组 A 则利用其包膜(Env)糖蛋白来对抗人类 tetherin。其他 8 组 HIV-2 是否以及如何拮抗这种抗病毒因子仍不清楚。在这里,我们表明,来自不同组的 HIV-2 的 Nef 蛋白要么不拮抗,要么仅适度拮抗人类 tetherin,而它们下调 CD3 和 CD4 的能力高度保守。转染细胞系和感染原代细胞的实验表明,不仅流行的 HIV-2 组 A 的 Env 蛋白,而且循环重组形式(CRF01_AB)和罕见组 F 和 I 的 Env 蛋白也会降低人类 tetherin 的表面表达,并显著增强病毒颗粒的释放。有趣的是,我们发现许多 SIVsmm Envs 也拮抗人类和 smm tetherin。因此,不同组的 HIV-2 中的 Env 介导的 tetherin 拮抗可能源自其 SIVsmm 前体对人类的预先适应。总之,我们鉴定了 SIVsmm 的一种表型特征,这可能促进了它向人类的成功人畜共患病传播和 HIV-2 的出现。HIV-2 组 A 到 I 是 SIVsmm 向人类的九次独立跨物种传播事件的结果,它们在流行率和地理分布上有很大差异。因此,对这些病毒的详细特征分析提供了一种有价值的手段,可以阐明决定病毒传播的免疫逃逸机制和人类特异性适应。在对罕见和流行的 HIV-2 组及其灵长类 SIVsmm 对应物的系统比较中,我们发现 Nef 下调主要病毒进入受体 CD4 和 T 细胞受体 CD3 的能力是保守的,而对 CD28、CD74 和主要组织相容性复合物 I 表面表达的影响则有很大差异。此外,我们发现不仅 HIV-2 组 A、AB、F 和 I 的 Env 蛋白,而且一些 SIVsmm 分离株的 Env 蛋白也拮抗人类 tetherin。这一发现有助于解释为什么 SIVsmm 已经能够至少在九次独立的机会中跨越物种屏障进入人类。